 |
InterPro: IPR002156 Ribonuclease H
Protein matches
|
UniProtKB Matches: 10754 proteins |
|
Accession
|
IPR002156 RNase_H |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Parent
|
IPR012337 Polynucleotidyl transferase, ribonuclease H fold
|
|
Found in
|
IPR014636 RNase H, phosphoglycerate mutase domain-containing
IPR017067 Ribonuclease H1, eukaryote
|
GO Term annotation
|
|
Function
|
GO:0003676 nucleic acid binding
GO:0004523 ribonuclease H activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
The RNase H domain is responsible for hydrolysis of the RNA portion of RNA x DNA hybrids, and this activity requires the presence of divalent cations (Mg2+ or Mn2+) that bind its active site. This domain is a part of a large family of homologous RNase H enzymes of which the RNase HI protein from Escherichia coli is the best characterised [1]. Secondary structure predictions for the enzymes from E. coli, yeast, human liver and diverse retroviruses (such as Rous sarcoma virus and the Foamy viruses) supported, in every case, the five beta-strands (1 to 5) and four or five alpha-helices (A, B/C, D, E) that have been identified by crystallography in the RNase H domain of Human immunodeficiency virus 1 (HIV-1) reverse transcriptase and in E. coli RNase H [2]. Reverse transcriptase (RT) is a modular enzyme carrying polymerase and ribonuclease H (RNase H) activities in separable domains. Reverse transcriptase (RT) converts the single-stranded RNA genome of a retrovirus into a double-stranded DNA copy for integration into the host genome. This process requires ribonuclease H as well as RNA- and DNA-directed DNA polymerase activities.
Retroviral RNase H is synthesised as part of the POL polyprotein that contains; an aspartyl protease, a reverse transcriptase, RNase H and integrase. POL polyprotein undergoes specific enzymatic cleavage to yield the mature proteins. Bacterial RNase H EC:3.1.26.4 catalyses endonucleolytic cleavage to 5'-phosphomonoester acting on RNA-DNA hybrids.
The 3D structure of the RNase H domain from diverse bacteria and retroviruses
has been solved [3, 4, 5]. All have four beta
strands and four to five alpha helices. The E. coli RNase H1 protein
binds a single Mg2+ ion cofactor in the active site of the enzyme. The
divalent cation is bound by the carboxyl groups of four acidic residues,
Asp-10, Glu-48, Asp-70, and Asp-134 [4]. The first three acidic residues are
highly conserved in all bacterial and retroviral RNase H sequences.
|
Structural links
|
|
Database links
|
Pfam Clan: CL0219.10
|
Publications
|
|
1.
|
Goedken ER, Marqusee S.
Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Proteins 33 135-43 1998
[PubMed: 9741851]
http://dx.doi.org/10.1002/(SICI)1097-0134(19981001)33:1<135::AID-PROT12>3.3.CO;2-K
|
|
2.
|
Ey PL, Freeman NL, Bela B, Haese PM, Li P, McInnes JL.
Sequence and comparative structural analysis of the murine leukaemia virus amphotropic strain 4070A RNase H domain.
Arch. Virol. 144 2185-99 1999
[PubMed: 10603172]
http://dx.doi.org/10.1007/s007050050632
|
|
3.
|
Yang W, Hendrickson WA, Crouch RJ, Satow Y.
Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.
Science 249 1398-405 1990
[PubMed: 2169648]
http://www.sciencemag.org/cgi/content/abstract/249/4975/1398
|
|
4.
|
Katayanagi K, Okumura M, Morikawa K.
Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site.
Proteins 17 337-46 1993
[PubMed: 8108376]
http://dx.doi.org/10.1002/prot.340170402
|
|
5.
|
Davies JF 2nd, Hostomska Z, Hostomsky Z, Jordan SR, Matthews DA.
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.
Science 252 88-95 1991
[PubMed: 1707186]
http://www.sciencemag.org/cgi/content/abstract/252/5002/88
|
Additional Reading
|
|
Cerritelli SM, Frolova EG, Feng C, Grinberg A, Love PE, Crouch RJ.
Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice.
Mol. Cell 11 2003 807-15
[PubMed: 12667461]
http://dx.doi.org/10.1016/S1097-2765(03)00088-1
|
|
Tucker TJ, Saggar S, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai MT, Liang Y, McGaughey G, Liu M, Miller M, Moyer G, Munshi V, Perlow-Poehnelt R, Prasad S, Sanchez R, Torrent M, Vacca JP, Wan BL, Yan Y.
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations.
Bioorg. Med. Chem. Lett. 18 2008 2959-66
[PubMed: 18396399]
http://dx.doi.org/10.1016/j.bmcl.2008.03.064
|
|
Crouch RJ.
Ribonuclease H: from discovery to 3D structure.
New Biol. 2 1990 771-7
[PubMed: 2177653]
|
|
Dasgupta S, Masukata H, Tomizawa J.
Multiple mechanisms for initiation of ColE1 DNA replication: DNA synthesis in the presence and absence of ribonuclease H.
Cell 51 1987 1113-22
[PubMed: 2446774]
http://dx.doi.org/10.1016/0092-8674(87)90597-6
|
|
Bauman JD, Das K, Ho WC, Baweja M, Himmel DM, Clark AD Jr, Oren DA, Boyer PL, Hughes SH, Shatkin AJ, Arnold E.
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design.
Nucleic Acids Res. 36 2008 5083-92
[PubMed: 18676450]
http://dx.doi.org/10.1093/nar/gkn464
|
|
Tucker TJ, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai MT, Liang Y, McGaughey G, Liu M, Miller M, Moyer G, Munshi V, Perlow-Poehnelt R, Prasad S, Reid JC, Sanchez R, Torrent M, Vacca JP, Wan BL, Yan Y.
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
J. Med. Chem. 51 2008 6503-11
[PubMed: 18826204]
http://dx.doi.org/10.1021/jm800856c
|
|
Spallarossa A, Cesarini S, Ranise A, Ponassi M, Unge T, Bolognesi M.
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.
Biochem. Biophys. Res. Commun. 365 2008 764-70
[PubMed: 18035053]
http://dx.doi.org/10.1016/j.bbrc.2007.11.036
|
|
Zhao Z, Wolkenberg SE, Lu M, Munshi V, Moyer G, Feng M, Carella AV, Ecto LT, Gabryelski LJ, Lai MT, Prasad SG, Yan Y, McGaughey GB, Miller MD, Lindsley CW, Hartman GD, Vacca JP, Williams TM.
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Bioorg. Med. Chem. Lett. 18 2008 554-9
[PubMed: 18083561]
http://dx.doi.org/10.1016/j.bmcl.2007.11.085
|
|